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Objective: to compare the additional prognostic value of Dobutamine Stress Echocardiography (DSE), Dipyridamole
Stress Echocardiography (DiSE) and Perfusion Scintigraphy (DTS) on clinical risk factors in patients undergoing major
vascular surgery.
Design: retrospective analysis.
Materials: 2204 consecutive patients who underwent DSE (n 1093), DiSE (n 394), or DTS (n 717) testing before
major vascular surgery were studied.
Methods: primary endpoint was a composite of cardiac death and non-fatal myocardial infarction (MI). Logistic regression
analysis was performed to evaluate the relation between cardiac risk factors, stress test results and the incidence of the
composite endpoint.
Results: there were 138 patients (6.3%) with cardiac death or MI. Patients with 0, 1±2, and 3 or more risk factors
experienced respectively 3.0, 5.7 and 17.4% cardiac events. We found no statistically significant difference in the predictive
value of a positive test result for DiSE and DSE (Odds ratio (OR) of 37.1 [95% CI, 8.1±170.1] vs 9.6 [95% CI, 4.9±18.4];
p 0.12), whereas a positive test result for DTS had significantly lower prognostic value (OR 1.95 [95% CI, 1.2±3.2]).
Conclusion: a result of stress echocardiography effectively stratified patients into low- and high-risk groups for cardiac
complications, irrespective of clinical risk profile. In contrast, the prognostic value of DTS results was more likely to be
dependent on patients' clinical risk profile.
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stress echocardiography; Dipyridamole perfusion scintigraphy.
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Patients undergoing major vascular surgery are at
increased risk of cardiovascular complications, such
as cardiac death and nonfatal myocardial infarction
(MI), due to underlying coronary artery disease
(CAD).1 These complications may occur during or
directly after surgery. Evaluation of CAD is often dif-
ficult since patients have limited exercise capacity.
Therefore, multiple non-exercise dependent stress
tests have been developed. It has been suggested
that the most accurate information on the individual
patient's risk can be obtained by a combination of
clinical characteristics and results of dipyridamole
perfusion scintigraphy (DTS).2 Recently, the use of
pharmacological stress echocardiography either withPlease address all correspondence to: D. Poldermans, Department
of Vascular Surgery, Room H921, Erasmus Medical Centre;
Dr Molewaterplein 40, 3015GD Rotterdam, The Netherlands.
1078±5884/02/03022208 $35.00/0 # 2002 Elsevier Science Ltd. Alldipyridamole (DiSE)3±6 or dobutamine (DSE)7±13 has
been proposed for risk stratification.
Pharmacological stress echocardiography has
proved to be a safe and sensitive technique for pre-
dicting perioperative cardiac events, with an excellent
negative predictive power.6,9 However, it has not been
well established, which of the available tests is best for
predicting perioperative cardiac complications. The
purpose of this investigation was to compare the ability
of dipyridamole and dobutamine stress echocardio-
graphy, and dipyridamole stress perfusion scinti-
graphy to predict perioperative cardiac events in large
cohorts of patients undergoing major vascular surgery.
Materials and Methods
Description of the study population
The study population consisted of 2204 consecutive
patients undergoing preoperative screening with onerights reserved.
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abdominal aortic surgery or infrainguinal procedure.
Dobutamine stress echocardiography
Dobutamine stress echocardiography was performed
according to study protocol in 1093 consecutive
patients who participated in the Dutch Echocardio-
graphic Cardiac Risk Evaluation Applying Stress
Echocardiography study (DECREASE) between 1996
and 1999.9,14 Two investigators who were aware of the
doses of dobutamine and atropine used during tests
were blinded to clinical information and performed
off-line assessment of echocardiographic images. The
left ventricle was divided into 16 segments and
wall motion was scored on a 5-point ordinal scale;
(1) normal wall motion; (2) mild hypokinesis; (3)
severe hypokinesis; (4) akinesis and (5) dyskinesis.
For each patient, a wall motion score index was cal-
culated at rest and during peak stress. The results of
DSE were considered positive if new wall-motion
abnormalities (NWMAs) occurred.
Dipyridamole stress testing
Dipyridamole stress echocardiography
Dipyridamole stress echocardiography was per-
formed according to study protocol in 394 pros-
pectively enrolled patients who participated in the
Echo Persantin International Cooperative study
(EPIC) between 1994±1998.6 Patients were screened
with DiSE prior to their scheduled vascular surgery.15
During the procedure, 2-dimensional echocardio-
graphic, 12-lead ECG, and blood pressure monitoring
were continuously performed. Regional wall motion
and test positivity was assessed for DiSE testing.
Aminophylline was given at the end of the test.
Assessment of stress echocardiography performance
was performed using predefined criteria for stress
echocardiography reading.16
Dipyridamole thallium perfusion scintigraphy
Dipyridamole thallium-201 scintigraphy was per-
formed in 717 consecutive patients between 1984
and 1991, who were referred to DTS testing before
major elective vascular surgery at the following insti-
tutes: University of Massachusetts Medical Center
(n 360),17 Massachusetts General Hospital (n 246),2
Medical Center Hospital of Vermont (n 111).18 Base-
line clinical and test characteristics were prospectively
collected for all but one study.2 The DTS test was
performed according to a previously describedstandardised protocol.19,20 The test was administered
and interpreted by experienced nuclear cardiologists
who were blinded to the patients' clinical course.
Planar thallium imaging was used at all centres.
Initial images were obtained in three standard
views (anterior, left anterior oblique, and lateral)
immediately after the administration of dipyridamole
and thallium, and delayed images were obtained on
average 3 h later. A positive test result for DTS was
defined as planar myocardial scintigraphic images,
revealing images exhibiting defects, which were
partially or completely redistributed on delayed
(43 h) images.
Definition of cardiac endpoint
For the present study, a composite of cardiac death
and nonfatal myocardial infarction (MI) occurring
within 30 days after surgery was chosen. Cardiac
death was defined as death directly attributable
to myocardial infarction, congestive heart failure, or
ventricular arrhythmia in the absence of any other
precipitating factor. Myocardial infarction was diag-
nosed by either serum creatinine-kinase level of more
than 110 U/L with a myoglobin isoenzyme fraction
of more than 10%, or by new electrocardiographic
Q waves 1 mm, or faster than 30 ms in duration.
Clinical risk factors
Potential clinical determinants of perioperative car-
diac events were selected by review of the current
published literature, and included: advanced age
(470 years), a current or stable angina pectoris (AP),
a history of MI, a history of heart failure, and a history
of diabetes mellitus (DM). Current stable angina
pectoris was characterised according to the Canadian
Cardiovascular Society Angina Classification.21
History of MI was defined as a documented history
of a MI or a finding of pathologic Q waves on electro-
cardiography. Congestive heart failure was defined
according to the presence of a history of symptoms
or signs of pulmonary congestion, signs of left or right
ventricular failure and chest radiographic findings
suggestive of heart failure. Diabetes mellitus was
defined by a predefined criterion used in each study.
Statistical analysis
Differences in baseline clinical characteristics
between the study populations were evaluated byEur J Vasc Endovasc Surg Vol 24, September 2002
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priate. Despite the observed differences, we considered
the patients in the separate datasets to be representa-
tive of all patients undergoing elective vascular sur-
gery. Thus, the individual datasets were combined.
Univariate and multivariate logistic regression ana-
lyses were performed to study the prognostic value
of the selected clinical characteristics with respect to
composite endpoint. Information on heart failure was
missing in 35% of patients. In order to include heart
failure in the regression analysis missing values were
imputed based on the mean value (0.072) of patients
either with (value 1) or without (value 0) a history of
heart failure. All clinical variables entered the multi-
variate model irrespective of the results of the univari-
ate analyses. Based on the results of the multivariate
analysis a simple clinical risk score was composed.
Subsequently, logistic regression analyses were
applied to predict the prognostic value of a positive
test result. Differences in prognostic value between
the tests (DSE, DiSE, DTS) were evaluated by compar-
ing the regression coefficients associated with the test
result using the t-test. Finally, the additional prognos-
tic value of a positive test result upon the clinical risk
score was studied by additional logistic regression
analyses. Odds ratios (ORs) and corresponding 95%
confidence intervals (CIs) are reported. The predictive
power of regression models was quantified by
the c-index, which is identical to the area under the
receiver operating characteristic curve; the c-index
ranges from 0.5 (not predictive at all) to 1.0 (optimal
performance).Table 1. Clinical characteristics of the patient populations
Clinical characteristics DSE
Patients' no. 1093
Demographics
Age 70 years 557 (51%
Men 851 (78%
History x
Current or stable angina pectoris 222 (20%
History of myocardial infarction 473 (43%
History of congestive heart failure 70 (6%)
History of diabetes mellitus 168 (15%
Test result y
Test positivity 216 (20%
Outcome
Cardiac death or myocardial infarction 43 (3.9%
DSE, dobutamine stress echocardiography; DiSE, dipyridam
perfusion scintigraphy; Ellipse indicates that data is not ava
yTest positivity of DSE and DiSE were considered positive
images exhibiting defects, which partially or completely red
}For definition of clinical risk factors see `` Methods'' section
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There were important differences in clinical baseline
characteristics and test results between the popu-
lations (Table 1). Patients in the DSE group were
older, and more often had a history of MI than patients
undergoing either DiSE or DTS. The majority of
patients in the DiSE populations were males, and the
prevalence of risk factors was somewhat lower than in
the other two populations. Patients undergoing DTS
more often had current stable angina pectoris, history
of heart failure, diabetes, and a positive test result
than patients undergoing DSE or DiSE testing
(Table 1). There were also differences in the incidence
of adverse cardiac outcome: 43 patients had events
(3.9%) among 1093 patients undergoing DSE, 14
(3.6%) in 394 patients with DiSE and 81 (11.5%) in
717 patients undergoing DTS.
Predictive value of clinical risk factors
The relation between clinical variables and the inci-
dence of the composite endpoint is shown in Table 2.
Patients with current stable angina, a history of MI or
diabetes had more than a 2-fold increased risk of
perioperative cardiac events than those without such
a history. A history of heart failure was another
important clinical determinant of perioperative car-
diac complications associated with a 4-fold increased
risk in patients with such a history compared to
those without. Surprisingly, advanced age was not.
DiSE DTS p value
394 717
) 159 (40%) 301 (42%) 50.001
) 356 (90%) 347 (48%) 50.001
) 51 (13%) 185 (26%) 50.001
) 86 (22%) 215 (30%) 50.001
± 34 (4.7%) 0.120
) 37 (9%) 149 (21%) 50.001
) 65 (17%) 198 (28%) 50.001
) 14 (3.6%) 81 (11.5%) 0.001
ole stress echocardiography; DTS, dipyridamole thallium
ilable.
if new wall-motion abnormalities occurred; and for DTS if
istributed on delayed (43 h) images.
.
Table 2. Univariable and multivariable relation between clinical baseline characteristics and perioperative cardiac
death and myocardial infarction.
Clinical variables Event
(n 138) x (%)
No event
(n 2053) (%)
Univariable odds
ratio (95% CI)
Multivariable odds
ratio (95% CI)
Age 70 years 71 (51) 939 (46) 1.3 (0.9±1.8) y 1.3 (0.9±1.9) y
Current or stable angina pectoris 51 (37) 403 (20) 2.4 (1.7±3.4) k 2.0 (1.3±2.9) k
History of myocardial infarction 72 (52) 699 (34) 2.1 (1.5±3.0) k 1.6 (1.1±2.4) z
History of heart failure 17 (12) 87 (4) 4.5 (2.5±8.2) k 2.4 (1.4±4.3) z
History of diabetes mellitus 40 (29) 310 (15) 2.3 (1.6±3.4) k 2.1 (1.4±3.1) k
Numbers may not add to 2204 due to missing data; For definitions of the clinical variables see `` Methods'' section;
CI, confidence interval.
xEvent is specified as a composite of cardiac death and nonfatal myocardial infarction.
y p4 0.05; { p5 0.05; k p5 0.001.
Table 3. Univariable and multivariable models to predict perioperative cardiac death or myocardial infarction.
Variables No. of
Patients
Event, No.
(%)
Univariable Odds
Ratios (95% CI)
Multivariable Odds
Ratios (95% CI)
Multivariable w2 p value
Clinical risk score
Score 0 539 16 (3.0) 1.0 1.0
Score 1 to 2 1416 81 (5.7) 2.0 (1.1±3.4) 1.8 (1.0±3.0) 4.0 0.045
Score 3 236 41 (17.4) 6.9 (3.8±12.7) 4.6 (2.5±8.6) 23.7 50.001
Stress echocardiography summary x
No new wall-motion abnormalities 1206 16 (1.3) 1.0 1.0
New wall-motion abnormalities 281 41 (14.6) 12.7 (7.0±23.0) 10.1 (5.5±18.5) 56.7 50.001
Perfusion scintigraphy summary x
No reversible perfusion defect 519 48 (9.2) 1.0 1.0
Reversible perfusion defect 198 33 (16.7) 1.9 (1.2±3.2) 1.6 (0.9±2.6) 3.4 0.066
Numbers may not add to 2204 due to missing data; Event, defined as a composite of cardiac death and nonfatal myocardial infarction;
Variables that composed the clinical risk score were advanced age, current or stable angina, a history of myocardial infarction, a history of
congestive heart failure and diabetes mellitus.
x In the multivariable analysis dummy variables were introduced in order to account for the fact that patients with stress echocardiography
did not undergo perfusion scintigraphy, and patients with perfusion scintigraphy did not undergo stress echocardiography.
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cardiac outcome. The multivariable model showed
that current or stable angina, a history of MI, heart
failure and diabetes mellitus remained important inde-
pendent determinants of cardiac outcome (Table 2).
The multivariable odds ratios for current or stable
angina, a history of MI, and diabetes slightly
decreased, whereas the odds ratio for heart failure
almost halved compared to its univariable estimate.
Based on these results, a simple risk score was devel-
oped to aggregate the available clinical information.
To compose the clinical risk score one point was
assigned to each of the following characteristics:
age 70 years, current or stable angina, history of
MI, history of heart failure and diabetes. Despite the
fact that advanced age was not a significant risk factor
in the present analysis it was included in the risk score
because of its confirmed predictive value in previous
studies.8,9 In all, 539 (25%) had a risk score 0, 1416
(64%) had an index of 1 to 2, and 236 (11%) had a risk
score of 3 or more points. The incidence of the com-
posite endpoint in these patients was 3.0, 5.7 and17.4% (p5 0.001). Regression analysis revealed a 2-
fold increased risk for the composite endpoint asso-
ciated with a risk score 1 to 2, and an almost 7-fold
increased risk associated with a risk score 3 or more
points (Table 3). Additional multivariate analyses
demonstrated the prognostic value of clinical risk
scores.
Predictive value of a positive test result
Patients who had NWMAs during DiSE had a 37-fold
(OR 37.0 [95% CI, 8.1±170.1]) increased risk of
adverse cardiac events compared to those without
NWMAs during DiSE. The presence of stress-induced
ischaemia during DSE also was associated with
the risk of perioperative cardiac complications
(OR 9.6 [95% CI, 4.9±18.4]). A comparison of uni-
variate standardised beta coefficients (DiSE,
[b 3.6 0.8] vs DSE, [b 2.3 0.3]) showed that
there was no statistically significant difference in the
predictive value of a positive test result for DiSE
and DSE (p 0.12). Therefore, pharmacologic stressEur J Vasc Endovasc Surg Vol 24, September 2002
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Fig. 1. Estimated risk of perioperative cardiac death or myocardial
infarction based on clinical characteristics and results of pharmaco-
logic stress echocardiography or dipyridamole perfusion scinti-
graphy. Panel A represents the estimated cardiac event rate
(a composite of cardiac death and non-fatal myocardial infarction)
based on the clinical risk score and the results of pharmacologic
stress echocardiography. Negative pharmacologic stress echo-
cardiography; Risk score; Positive pharmacologic stress
echocardiography. Panel B represents the estimated cardiac
event rate (a composite of cardiac death and non-fatal myocardial
infarction) based on the clinical risk score and the results of dipyri-
damole perfusion scintigraphy. Negative dipyridamole per-
fusion scintigraphy; Risk score Positive dipyridamole
perfusion scintigraphy.
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modality irrespective of the pharmacologic agent
(dobutamine vs dipyridamole) used for inducing
myocardial ischaemia. A regression analysis of a test
positivity then revealed that patients with NWMAs
during pharmacologic stress echocardiography were
at significantly higher risk for cardiac death or MI
(OR 12.7 [95% CI, 7.0±23.0]) than those without
NWMAs. The predictive value of a positive test result
during DTS (OR 1.9 [95% CI, 1.2±3.2]) had signifi-
cantly lower prognostic value compared to pharmaco-
logic stress echocardiography (pharmacologic stress
echocardiography, [b 2.5 0.3] vs DTS [b 0.7 0.2];
p5 0.001).
In a univariate analysis, important determinants of
perioperative cardiac complications were a presence
of 1 to 2 and 3 or more risk scores, and positive test
results for pharmacologic stress echocardiography
and a positive test result for DTS (Table 3). In a multi-
variate analysis the clinical risk scores were combined
with the test results, and only the scores themselves,
and the presence of NWMAs remained important
determinants of perioperative cardiac outcome. A
presence of a positive test result for DTS lost most of
its predictive power with respect to the composite
endpoint (Table 3).
The logistic regression model with the clinical risk
score had satisfactory ability to discriminate between
patients who did and did not have a perioperative
cardiac complication (c-index 0.66). The multivariable
model that combined clinical data with test result
had considerably better discriminating power with
a c-index of 0.80.
Risk classification model
Based on the results described above, a simple scheme
was developed to estimate a patient's risk of peri-
operative cardiac complications (Fig. 1). If the clinical
risk score was in the range of 0 or 1 to 2 points and
stress echocardiography was negative, the estimated
cardiac complication rate was low. The estimated risk
of cardiac complications was also low in patients with
risk score of 3 or more points without NWMAs (Fig. 1,
panel A). Patients with a risk score of 0, 1 to 2 as well
as 3 or more points, and with NWMAs were at
a considerable risk (Fig. 1, panel A). In contrast, the
magnitude of difference between negative and posi-
tive test results for DTS showed a different pattern.
The prognostic value of DTS seemed to be dependent
on the clinical risk profile of patients, but the formal
statistical test of heterogeneity failed to show signi-
ficance. This test had no predictive value in patientsEur J Vasc Endovasc Surg Vol 24, September 2002with a risk score 0, but its predictive value increased in
patients with risk scores 1 to 2, and 3 or more points
(Fig. 1, panel B).
Discussion
This study compared the additional prognostic cap-
ability of three noninvasive tests upon clinical risk
factors used for perioperative cardiac risk assessment
in large groups of patients who underwent major
vascular surgery. The present analysis of 2204 major
vascular surgery patients demonstrated that current
or stable angina, a history of myocardial infarction,
heart failure and diabetes mellitus are the most
important clinical determinants of perioperative car-
diac death or MI. Pharmacologic stress echocardiog-
raphy results were highly predictive of adverse
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stressor used, which also confirms the results of
other investigations.6,7 In contrast, the prognostic
value of DTS results was more likely to be dependent
on patients' clinical risk profile.
Clinical risk factors for cardiac complications
Preoperative cardiac risk assessment of patients
undergoing major vascular surgery is one of the
most challenging and controversial areas of clinical
medicine. Several large studies demonstrated that
perioperative cardiac complications are particularly
high in patients undergoing major vascular surgery.2,6,7
Patients are at particularly high risk when they are
 70 years old, and have a history or symptoms of
CAD. In the present study, the selected group of risk
factors stratified patients into low-, intermediate- and
high-risk groups for cardiac complications. However,
clinical variables alone did not provide an adequate
power for stratification. Using pharmacologic stress
echocardiography patients could be effectively strati-
fied into group with very low estimated cardiac com-
plication rate. The additional value of DTS imaging
upon clinical risk factors showed a different pattern.
Patient with a negative DTS results did remain at high
risk for cardiac complications and there was no differ-
ence in the event rate between patients who had and
did not have a perioperative adverse cardiac outcome.
Pharmacologic stress echocardiography
Pharmacologic stress echocardiography with dobuta-
mine or dipyridamole is now widely accepted as an
alternative stress test for patients unable to exercise.
Stress echocardiography with dobutamine has proven
to be a useful method for detection of CAD, and as
a predictor of perioperative cardiac events in patients
undergoing vascular surgery.7±9 In contrast to other
coronary vasodilators, dobutamine directly increases
myocardial oxygen demand through positive chrono-
tropic and inotropic effects, and also impairs myo-
cardial oxygen supply by reducing the duration of
systole. These factors may induce ischaemia if supply
cannot meet the increased demand. The addition of
atropine further increases heart rate and improves the
sensitivity of the test without increasing side effects.
In contrast to dobutamine, dipyridamole induces
coronary hyperaemia, which leads to coronary steal22
and can result in myocardial ischaemia characterised
by stress-induced regional dysfunction. In theory,
stress echocardiography with dipyridamole isconsidered less effective in inducing new wall motion
abnormalities, especially for milder forms of CAD.
However, in our study there was not statistically
significant difference in the predictive value of a posi-
tive test result for dipyridamole vs dobutamine stress
echocardiography. The present study confirmed the
findings of a small-scale study, which directly com-
pared dipyridamole vs dobutamine stress echocardio-
graphy.23 They found that the two tests had excellent
negative predictive values for perioperative cardiac
events and similar comparable positive predictive
values.
Dipyridamole perfusion scintigraphy
The most extensively studied non-invasive approach
to the cardiac risk stratification is DTS in combination
of clinical risk factors. The presence of dipyrida-
mole induced flow heterogeneity has been shown to
be highly sensitive for the detection of coronary
stenoses.17 In practice, it implies that significant
coronary stenoses are rarely missed, thus allowing
a negative DTS imaging test to have a high predictive
value for patients having no cardiac events after
surgery.2,19,20 In the present study, the prognostic
value of DTS results was more likely to be dependent
on patients' clinical risk profile. In patients at low-risk
for cardiac complications test results did not differen-
tiate between those who did and did not have a cardiac
complication. In part, this observation suggests that
the specificity of scintigraphy is less satisfactory com-
pared to pharmacologic stress echocardiography.
Artefacts and possible inclusion of unselected group
of patients at high risk for false-positive perfusion
scintigrams may have influenced the observed
prognostic value of the test. Thus, it seems that DTS
should be performed in patients at higher risk for
cardiac complications such as patients with 1 to 2, or
3 or more cardiac risk factors.
Our study also revealed that a positive DTS result
had significantly lower prognostic value than pharma-
cologic stress echocardiography. In agreement with
our findings, current evidence suggests that the avail-
able data from direct comparison of dipyridamole
echocardiography testing vs perfusion imaging
suggest that perfusion defects are more frequent than
transient dyssynergies and have a lower predictive
value.5 There are no studies to date that directly com-
pare DSE and DTS in the same patient population.
Hence, comparison of these two noninvasive tests
can only be derived from the published reports.
A recent meta-analysis comparing DSE and DTS
concluded that the prognostic value of the twoEur J Vasc Endovasc Surg Vol 24, September 2002
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and DTS but accuracy varied with CAD prevalence.24
Study limitations
This study has certain limitations, which should be
considered when interpreting the results. Three differ-
ent noninvasive tests were compared for their ability
to predict the incidence of perioperative cardiac
events in three separate patient populations studied
at different points in time in different hospitals. In
order to study their relation to clinical risk factors,
test characteristics the three datasets were combined.
The differences in the prevalence of selected risk
factors between the datasets, and the fact that patients
were selected at different points in time in different
hospitals may have biased the estimation of the pre-
dictive value of each test. However, by merging the
datasets major vascular surgery patients in the present
study could represent a wider range of patients.
In the present study DTS patients underwent planar
perfusion scintigraphy, which reflects the available
imaging technique at that time. Since then, single-
photon computed tomography (SPECT) has been
introduced.25±27 Baron et al., however, questioned
the predictive value of SPECT. They found that it did
not provide additional prognostic information over
clinical risk factors.25 Thus, we assume that our results
remain applicable.
Due to the retrospective nature of this study infor-
mation on risk factors such as smoking, hypertension
and renal failure were not available in all datasets as
well as the use of concomitant cardiac medication in
the two of the three datasets was unavailable. Includ-
ing information on these risk factors and perioperative
cardiac medication such as beta-blockers could help to
further elucidate the nature of the predictive values of
these three noninvasive tests.
Conclusion
This study confirmed the utility of clinical risk factors
and additional non-invasive testing in preoperative
management of patients undergoing major vascular
surgery. The decision between myocardial perfusion
imaging and stress echocardiography either with
dobutamine or dipyridamole is influenced by numer-
ous factors. Stress echocardiography has many prac-
tical advantages over nuclear perfusion imaging-due
to its lower costs, wider availability, reduced imaging
time, and absence of radiation exposure. The results of
the present study suggest that pharmacological stressEur J Vasc Endovasc Surg Vol 24, September 2002echocardiography either with dipyridamole or dobu-
tamine appears to have more favourable prognostic
performance, irrespective of clinical risk profile. In
contrast, the prognostic value of DTS results was
more likely to be dependent on patients' clinical
risk profile. In order to confirm these findings future
randomised clinical trials with large number of
patients are necessary. The physician's choice of
preoperative cardiac testing, however, should also
take into account factors such as local expertise and
experience, availability, and costs.
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